Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pathological Response Prediction to Neo-adjuvant Chemoradiotherapy in Esophageal Carcinoma and Comparison of Engineered Features Versus Deep Learning Models

NCT04489368 is registered in ClinicalTrials.gov with Dr Kundan Singh Chufal as lead sponsor.

NCT NCT04489368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04489368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pathological Response Prediction to Neo-adjuvant Chemoradiotherapy in Esophageal Carcinoma and Comparison of Engineered Features Versus Deep Learning Models
Lead sponsor
Dr Kundan Singh Chufal
Phase
Observational
Overall status
Unknown status
Start date
January 16, 2020
Completion date
July 31, 2023
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal neoplasm